371 related articles for article (PubMed ID: 15670213)
41. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
[TBL] [Abstract][Full Text] [Related]
42. GATA-1: friends, brothers, and coworkers.
Morceau F; Schnekenburger M; Dicato M; Diederich M
Ann N Y Acad Sci; 2004 Dec; 1030():537-54. PubMed ID: 15659837
[TBL] [Abstract][Full Text] [Related]
43. Erythropoiesis: model systems, molecular regulators, and developmental programs.
Tsiftsoglou AS; Vizirianakis IS; Strouboulis J
IUBMB Life; 2009 Aug; 61(8):800-30. PubMed ID: 19621348
[TBL] [Abstract][Full Text] [Related]
44. Development of hematopoietic cells lacking transcription factor GATA-1.
Pevny L; Lin CS; D'Agati V; Simon MC; Orkin SH; Costantini F
Development; 1995 Jan; 121(1):163-72. PubMed ID: 7867497
[TBL] [Abstract][Full Text] [Related]
45. Primitive erythropoiesis in the mammalian embryo.
Palis J; Malik J; McGrath KE; Kingsley PD
Int J Dev Biol; 2010; 54(6-7):1011-8. PubMed ID: 20711979
[TBL] [Abstract][Full Text] [Related]
46. Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element.
Rojas A; De Val S; Heidt AB; Xu SM; Bristow J; Black BL
Development; 2005 Aug; 132(15):3405-17. PubMed ID: 15987774
[TBL] [Abstract][Full Text] [Related]
47. BP1 is a negative modulator of definitive erythropoiesis.
Mpollo MS; Beaudoin M; Berg PE; Beauchemin H; D'Agati V; Trudel M
Nucleic Acids Res; 2006; 34(18):5232-7. PubMed ID: 17003054
[TBL] [Abstract][Full Text] [Related]
48. Characteristics of in vivo murine erythropoietic response to sodium orthovanadate.
Aguirre MV; Juaristi JA; Alvarez MA; Brandan NC
Chem Biol Interact; 2005 Sep; 156(1):55-68. PubMed ID: 16137666
[TBL] [Abstract][Full Text] [Related]
49. Multipotential differentiation ability of GATA-1-null erythroid-committed cells.
Kitajima K; Zheng J; Yen H; Sugiyama D; Nakano T
Genes Dev; 2006 Mar; 20(6):654-9. PubMed ID: 16543218
[TBL] [Abstract][Full Text] [Related]
50. Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
Choe KS; Radparvar F; Matushansky I; Rekhtman N; Han X; Skoultchi AI
Cancer Res; 2003 Oct; 63(19):6363-9. PubMed ID: 14559825
[TBL] [Abstract][Full Text] [Related]
51. Erythroid expansion and survival in response to acute anemia stress: the role of EPO receptor, GATA-1, Bcl-xL and caspase-3.
Aispuru GR; Aguirre MV; Aquino-Esperanza JA; Lettieri CN; Juaristi JA; Brandan NC
Cell Biol Int; 2008 Aug; 32(8):966-78. PubMed ID: 18485751
[TBL] [Abstract][Full Text] [Related]
52. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line.
Weiss MJ; Yu C; Orkin SH
Mol Cell Biol; 1997 Mar; 17(3):1642-51. PubMed ID: 9032291
[TBL] [Abstract][Full Text] [Related]
53. Loss of Hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation.
Battista S; Pentimalli F; Baldassarre G; Fedele M; Fidanza V; Croce CM; Fusco A
FASEB J; 2003 Aug; 17(11):1496-8. PubMed ID: 12824305
[TBL] [Abstract][Full Text] [Related]
54. Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice).
Vannucchi AM; Bianchi L; Cellai C; Paoletti F; Carrai V; Calzolari A; Centurione L; Lorenzini R; Carta C; Alfani E; Sanchez M; Migliaccio G; Migliaccio AR
Blood; 2001 May; 97(10):3040-50. PubMed ID: 11342429
[TBL] [Abstract][Full Text] [Related]
55. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.
Del Vecchio GC; Giordani L; De Santis A; De Mattia D
Acta Haematol; 2005; 114(2):113-6. PubMed ID: 16103636
[TBL] [Abstract][Full Text] [Related]
56. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1.
Ribeil JA; Zermati Y; Vandekerckhove J; Cathelin S; Kersual J; Dussiot M; Coulon S; Moura IC; Zeuner A; Kirkegaard-Sørensen T; Varet B; Solary E; Garrido C; Hermine O
Nature; 2007 Jan; 445(7123):102-5. PubMed ID: 17167422
[TBL] [Abstract][Full Text] [Related]
57. Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions.
Freson K; Thys C; Wittewrongel C; Vermylen J; Hoylaerts MF; Van Geet C
Hum Genet; 2003 Jan; 112(1):42-9. PubMed ID: 12483298
[TBL] [Abstract][Full Text] [Related]
58. GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis.
Onodera K; Takahashi S; Nishimura S; Ohta J; Motohashi H; Yomogida K; Hayashi N; Engel JD; Yamamoto M
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4487-92. PubMed ID: 9114016
[TBL] [Abstract][Full Text] [Related]
59. Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage.
Ohneda K; Yamamoto M
Acta Haematol; 2002; 108(4):237-45. PubMed ID: 12432220
[TBL] [Abstract][Full Text] [Related]
60. Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia.
Shimizu R; Ohneda K; Engel JD; Trainor CD; Yamamoto M
Blood; 2004 Apr; 103(7):2560-7. PubMed ID: 14656885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
